Survodutide: all 35 studies that test it

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightNot yet recruitingNCT07855900Phase 3
• ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver DiseaseNot yet recruitingNCT07850063Phase 3
• SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose WeightNot yet recruitingNCT07850050Phase 3
• A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or ObesityRecruitingNCT07768813Phase 1
• A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarRecruitingNCT07754461Phase 3
• Albuminuria Reduction Study With Survodutide Treatment in Kidney DiseaseNot yet recruitingNCT07206290Phase 2
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruitingNCT06632457Phase 3
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisRecruitingNCT06632444Phase 3
• A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)CompletedNCT04771273Phase 2Results posted
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose WeightCompletedNCT04667377Phase 2Results posted
• A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.CompletedNCT04153929Phase 2Results posted
• A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like InjectorCompletedNCT07413913Phase 1
• A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the BodyCompletedNCT07221591Phase 1
• A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the BodyCompletedNCT07071974Phase 1
• A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the BodyCompletedNCT06772532Phase 1
• A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With ObesityActive, not recruitingNCT06745284Phase 1
• A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or ObesityCompletedNCT06564441Phase 1
• A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the BodyCompletedNCT06492135Phase 1
• A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain ActivityCompletedNCT06352424Phase 1
• A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney ProblemsCompletedNCT06352411Phase 1
• A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)CompletedNCT06309992Phase 3
• A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose WeightCompletedNCT06214741Phase 3
• A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or ObesityCompletedNCT06200467Phase 1
• A Study to Test Whether Survodutide Helps Japanese People Living With Obesity DiseaseCompletedNCT06176365Phase 3
• A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)CompletedNCT06077864Phase 3
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose WeightCompletedNCT06066528Phase 3
• A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightCompletedNCT06066515Phase 3
• A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the BloodCompletedNCT05896384Phase 1
• A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906CompletedNCT05751226Phase 1
• A Study in Healthy Men to Test How BI 456906 is Processed in the BodyCompletedNCT05421338Phase 1
• A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906CompletedNCT05296733Phase 1
• A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the LiverActive, not recruitingNCT05202353Phase 1
• A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2CompletedNCT04384081Phase 1
• A Study to Test Different Doses of BI 456906 in Patients With ObesityCompletedNCT03591718Phase 1
• Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male VolunteersCompletedNCT03175211Phase 1

← Survodutide overview